SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-14-000101
Filing Date
2014-12-10
Accepted
2014-12-10 16:01:23
Documents
4
Period of Report
2014-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201412108xkdoc.htm 8-K 31551
2 PRESS RELEASE pdli-201412108xkex991.htm EX-99.1 25436
3 INFORMATION SHEET pdli-201412108xkex992.htm EX-99.2 420477
4 pdl-logoa03a02a01a01.jpg GRAPHIC 59351
  Complete submission text file 0000882104-14-000101.txt   560576
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 141278012
SIC: 2836 Biological Products, (No Diagnostic Substances)